Skip to content

Dr Katerina Lalatsa

Reader in Nanomedicines

  1. 2020
  2. Accepted for publication

    Preformulation studies of a stable PTEN-PDZ lipopeptide able to cross an in vitro blood-brain-barrier model as a potential therapy for Alzheimer’s disease

    Dr Katerina Lalatsa, Yujiao Sun, Jose Ignacio Gamboa & Shira Knafo, 18 Aug 2020, (Accepted for publication) In : Pharmaceutical Research.

    Research output: Contribution to journalArticle

  3. Accepted for publication

    Tuning amphotericin B drug delivery across the skin: transferosomes for the treatment of cutaneous leishmaniasis and mycoses

    Raquel Fernandez-Garcia, Larry Statts, Jéssica A. de Jesus, Maria Auxiliadora Dea Ayuela, Liliana Bautista, Ruben Simao, Francisco Bolas-Fernandez, Maria Paloma Ballesteros, Marcia Dalastra Laurenti, Luiz Felipe Passero & 2 others, Dr Katerina Lalatsa & Dolores Remedios Serrano, 14 Aug 2020, (Accepted for publication) In : ACS Infectious Diseases.

    Research output: Contribution to journalArticle

  4. Accepted for publication

    Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis

    Dr Katerina Lalatsa, Larry Statts, Jéssica A. de Jesus, Olivia Adewusi, Maria Auxiliadora Dea Ayuela, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Passero & Dolores Remedios Serrano, 1 Aug 2020, (Accepted for publication) In : International Journal of Pharmaceutics.

    Research output: Contribution to journalArticle

  5. Accepted for publication

    Development and validation of stability indicating method for estimation of buparvaquone by forced degradation studies

    Shaikh Tanveer, Shelke Sushil, Dr Katerina Lalatsa & Kakde Rajendra, 8 Jun 2020, (Accepted for publication) In : Indian Journal of Pharmaceutical Education and Research.

    Research output: Contribution to journalArticle

  6. Published

    Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery

    Mohammad Fauzi Bin Bostanudin, Dr Katerina Lalatsa, Professor Darek Gorecki & Eugen Barbu, 15 May 2020, In : Carbohydrate Polymers. 236, 10 p., 116060.

    Research output: Contribution to journalArticle

  7. Published

    Personalised 3D printed medicines: optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms

    Jose R. Cerda, Talaya Arifi, Sejad Ayyoubi, Peter Knief, Mr William Malcolm Keeble, Maria Paloma Ballesteros, Eugen Barbu, Anne Marie Healy, Dr Katerina Lalatsa & Dolores Remedios Serrano, 11 Apr 2020, In : Pharmaceutics.

    Research output: Contribution to journalArticle

  8. Published

    Transcutaneous anaesthetic nano-enabled hydrogels for eyelid surgery

    Dr Katerina Lalatsa, Priyanka V Patel, Yujiao Sun, Chong C Kiun, Ferishtah Karimi, Dr Jurgita Zekonyte, Krisztina Emeriewen & George M. Saleh, 15 Mar 2020, In : International Journal of Pharmaceutics. 577, 9 p., 119003.

    Research output: Contribution to journalArticle

  9. 2019
  10. Early online

    Transferosomes as nanocarriers for drugs across the skin: QbD from lab to industrial scale

    Raquel Fernández-García, Dr Katerina Lalatsa, Larry Statts, Franscisco Bolás-Fernández, Maria Paloma Ballesteros & Dolores Remedios Serrano Lopez, 31 Oct 2019, In : International Journal of Pharmaceutics.

    Research output: Contribution to journalArticle

  11. Published

    Designing fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis

    Dolores Remedios Serrano Lopez, Raquel Fernandez-Garcia, Marta Mele, Anne Marie Healy & Dr Katerina Lalatsa, 1 Aug 2019, In : Pharmaceutics. 11, 8, 16 p., 369.

    Research output: Contribution to journalArticle

  12. Published

    Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis

    Adriana Bezzera-Souza, Raquel Fernandez-Garcia, Gabriela Rodrigues, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Passero, Dr Katerina Lalatsa & Dolores Remedios Serrano Lopez, 20 Jul 2019, In : Pharmaceutics. 11, 7, 14 p., 353.

    Research output: Contribution to journalArticle

  13. Published

    Drug delivery across the blood-brain barrier

    Dr Katerina Lalatsa, Andreas G. Schätzlein & Ijeoma F. Uchegbu, 17 Jul 2019, Comprehensive Biotechnology. Moo-Young, M. (ed.). 3rd ed. Elsevier, p. 628-637 10 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  14. Early online

    Technology enhanced learning in higher education: how to enhance student engagement through blended learning

    Dolores Remedios Serrano Lopez, Maria Auxiliadora Dea Ayuela, Elena Gonzalez-Burgos, Alfonso Serrano-Gil & Dr Katerina Lalatsa, 5 Apr 2019, In : European Journal of Education. 14 p.

    Research output: Contribution to journalArticle

  15. Published

    Tuning the transdermal delivery of hydroquinone upon formulation with novel permeation enhancers

    Dolores Remedios Serrano Lopez, Maria Jose Gordo, Antonio Matji, Salvador Gonzalez, Dr Katerina Lalatsa & Juan Jose Torrado, 4 Apr 2019, In : Pharmaceutics. 11, 4, 16 p., 167.

    Research output: Contribution to journalArticle

  16. Published

    Market demands in 3D printing pharmaceuticals products

    Dolores Remedios Serrano Lopez, Jose R. Carda, Raquel Fernandez-Garcia, Luiz Fernando Perez-Ballesteros, Maria Paloma Ballesteros Papantonakis & Dr Katerina Lalatsa, 29 Mar 2019, 3D Printing Technology in Nanomedicine. Ahmad, N., Gorinanth, P. & Dutta, R. (eds.). 1st ed. Pensylvania, USA: Elsevier

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  17. 2018
  18. Published

    Applying Loop-Mediated Isothermal Amplification (LAMP) in the diagnosis of malaria, leishmaniasis and trypanosomiasis as point-of-care tests (POCTs)

    Maria Auxiliadora Dea Ayuela, Christiana Galiana-Rosello, Dr Katerina Lalatsa & Dolores Remedios Serrano Lopez, 30 Nov 2018, In : Current Topics in Medicinal Chemistry. 18, 16, p. 1358-1374 17 p.

    Research output: Contribution to journalArticle

  19. Early online

    Applications of 3D printing in cancer

    Dolores Remedios Serrano Lopez, Maria C. Terres & Dr Katerina Lalatsa, 14 Aug 2018, In : Journal of 3D Printing in Medicine. 2, 3

    Research output: Contribution to journalLiterature review

  20. Published

    Which model of supervision is ideal for PhD students? A Spanish perspective

    Dolores Remedios Serrano Lopez, Elena Gonzalez-Burgos, Maria Auxiliadora Dea Ayuela, Alfonso Serrano-Gil & Dr Katerina Lalatsa, 21 Jun 2018.

    Research output: Contribution to conferencePoster

  21. Early online

    Orally bioavailable and effective buparvaquone lipid based nanomedicines for visceral leishmaniasis

    Lindsay Smith, Dolores Remedios Serrano Lopez, Marion Mauger, Francisco Bolas-Fernandez, Maria-Auxiliadora Dea Ayuela & Dr Katerina Lalatsa, 15 May 2018, In : Molecular Pharmaceutics. 15, 7, p. 2570-2583 14 p.

    Research output: Contribution to journalArticle

  22. Published

    Nanotechnology in brain targeting

    Dr Katerina Lalatsa, Diana Moreira Leite, Melina Fernandes Figueiredo & Max O'Connor, 27 Apr 2018, Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. Kesharwani, P. & Gupta, U. (eds.). 1st ed. Elsevier, p. 111-145 35 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  23. Published

    Physiology of the blood brain barrier (BBB) and mechanisms of transport across the BBB

    Dr Katerina Lalatsa & Professor Arthur Butt, 25 Apr 2018, Nanotechnology-based Targeted Drug Delivery Systems for Brain Tumors. Kesharwani, P. & Gupta, U. (eds.). 1st ed. Elsevier

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

Previous 1 2 3 Next

ID: 26358